|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-6-15
|
|
pubmed:abstractText |
A mass immunization campaign was implemented in 2001 to control a serogroup C meningococcal disease outbreak, and a newly licensed serogroup C meningococcal conjugate vaccine (C-MCV) was used. In 2002, 1 C-MCV dose was routinely offered to children 12 months of age.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1532-0987
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
566-9
|
|
pubmed:meshHeading |
pubmed-meshheading:21326136-Adolescent,
pubmed-meshheading:21326136-Adult,
pubmed-meshheading:21326136-Aged,
pubmed-meshheading:21326136-Aged, 80 and over,
pubmed-meshheading:21326136-Child,
pubmed-meshheading:21326136-Child, Preschool,
pubmed-meshheading:21326136-Female,
pubmed-meshheading:21326136-Health Services Research,
pubmed-meshheading:21326136-Humans,
pubmed-meshheading:21326136-Incidence,
pubmed-meshheading:21326136-Infant,
pubmed-meshheading:21326136-Male,
pubmed-meshheading:21326136-Meningococcal Infections,
pubmed-meshheading:21326136-Meningococcal Vaccines,
pubmed-meshheading:21326136-Middle Aged,
pubmed-meshheading:21326136-Quebec,
pubmed-meshheading:21326136-Vaccination,
pubmed-meshheading:21326136-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada.
|
|
pubmed:affiliation |
Department of Social and Preventive Medicine, Laval University, Quebec City, Canada. philippe.dewals@msp.ulaval.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
